LoadingLoadingLoadingNo insider open-market trades in 90 days (SEC Form 4). Congress: no trades disclosed in 180 days.
Analyst target and ratings are on paid plans
See the 12-month consensus target and the buy/hold/sell rating split.
Unlock the full results8 funds hold a position.
Buys/Adds (3)
Point72
$139.1M
bought
D.E. Shaw
$53.4M
bought
Qube Research
$26.3M
added
Top-trader positions in GSK could not be loaded.
Hyperliquid positioning - not every stock is covered
Last report
Jul 28, 2026
Period ending
Jun 30, 2026
Earnings per share
$1.27 expected
Revenue
Financial statements: Alpha Vantage
Estimates as of Oct 23, 2026
EPS expected
$1.31 to $1.34
Revenue expected
7 analysts
Last 30 days
Analysts cutting estimates
Estimate drift
Change in 30 days
| Period ending | Reported | EPS / estimate | EPS surprise | Revenue / income | Surprise |
|---|---|---|---|---|---|
| Jun 30, 2026 | Jul 28, 2026 | $1.36 / $1.27Alpha Vantage | +7.09% beat | GBP 8.41B No estimate | Unavailable |
| Mar 31, 2026 | Apr 29, 2026 | $1.26 / $1.16Alpha Vantage | +8.62% beat | GBP 7.63B No estimate | Unavailable |
| Dec 31, 2025 | Feb 4, 2026 | $0.70 / $0.62Alpha Vantage | +12.90% beat | $8.62B No estimate | Unavailable |
| Sep 30, 2025 | Oct 29, 2025 | $1.46 / $1.26Alpha Vantage | +15.87% beat | GBP 8.55B No estimate | Unavailable |
| Jun 30, 2025 | Jul 30, 2025 | $1.24 / $1.11Alpha Vantage | +11.71% beat | $7.99B No estimate | Unavailable |
| Mar 31, 2025 | Apr 30, 2025 | $1.20 / $1.04Alpha Vantage | +15.38% beat | GBP 7.52B No estimate | Unavailable |
| Dec 31, 2024 | Feb 5, 2025 | $0.58 / $0.49Alpha Vantage | +18.37% beat | GBP 8.12B No estimate | Unavailable |
| Sep 30, 2024 | Oct 30, 2024 | $1.29 / $1.16Alpha Vantage | +11.21% beat | GBP 8.01B No estimate | Unavailable |
EPS uses Yahoo Finance where available, then Alpha Vantage or verified release comparisons. Revenue and income use company releases, SEC filings, Alpha Vantage or Yahoo Finance. Non-USD revenue carries its currency code. Comparisons require a paired release estimate.
| USD | Jun 2025 | Dec 2025 |
|---|---|---|
| What came in | ||
| Revenue | $7.99B | $8.62B |
| Cost of what it sold | $2.17B | $2.66B |
| Gross profit | $5.82B | $5.96B |
| What it spent | ||
| Research and development | $2.02B | $2.35B |
| Sales and admin | $2.14B | $2.64B |
| Other operating costs | -$366.0M | -$534.0M |
| Total operating expenses | $3.80B | $4.46B |
| What was left | ||
| Operating profit | $2.02B | $1.51B |
| Interest on debt | $184.0M | $174.0M |
| Profit before tax | $1.89B | $950.0M |
| Tax | $241.0M | $223.0M |
| Net profit | $1.44B | $636.0M |
| EBITDA | $3.23B | $1.91B |
This stock is trending upward, and looks overbought after a fast run-up.
Trend
Constructive
60 / 100
RSI 14
20D volatility
52-week range
20D support
20D resistance
Returns
Price vs moving averages
Volume pace
